Viatris Current Ratio 2010-2024 | VTRS

Current and historical current ratio for Viatris (VTRS) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Viatris current ratio for the three months ending March 31, 2024 was 1.67.
Viatris Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2024-03-31 $12.92B $7.76B 1.67
2023-12-31 $12.98B $7.78B 1.67
2023-09-30 $10.93B $6.83B 1.60
2023-06-30 $9.78B $6.52B 1.50
2023-03-31 $9.63B $6.11B 1.58
2022-12-31 $10.64B $6.75B 1.58
2022-09-30 $10.49B $6.52B 1.61
2022-06-30 $11.18B $7.68B 1.46
2022-03-31 $11.74B $9.64B 1.22
2021-12-31 $10.90B $9.88B 1.10
2021-09-30 $11.31B $10.10B 1.12
2021-06-30 $11.75B $10.13B 1.16
2021-03-31 $12.32B $9.98B 1.24
2020-12-31 $12.87B $10.56B 1.22
2020-09-30 $7.34B $7.28B 1.01
2020-06-30 $6.47B $6.97B 0.93
2020-03-31 $6.60B $5.23B 1.26
2019-12-31 $6.76B $5.57B 1.21
2019-09-30 $6.65B $4.65B 1.43
2019-06-30 $6.27B $4.56B 1.37
2019-03-31 $6.26B $4.16B 1.51
2018-12-31 $6.37B $4.59B 1.39
2018-09-30 $6.54B $5.18B 1.26
2018-06-30 $6.30B $4.86B 1.30
2018-03-31 $6.76B $6.39B 1.06
2017-12-31 $7.21B $6.39B 1.13
2017-09-30 $7.27B $4.98B 1.46
2017-06-30 $6.97B $5.17B 1.35
2017-03-31 $7.07B $4.52B 1.56
2016-12-31 $7.52B $5.04B 1.49
2016-09-30 $7.97B $9.55B 0.83
2016-06-30 $12.19B $3.78B 3.23
2016-03-31 $6.63B $3.96B 1.67
2015-12-31 $6.47B $4.12B 1.57
2015-09-30 $6.49B $3.68B 1.76
2015-06-30 $7.89B $5.37B 1.47
2015-03-31 $7.43B $5.29B 1.40
2014-12-31 $6.44B $5.30B 1.21
2014-09-30 $5.82B $4.47B 1.30
2014-06-30 $4.48B $2.60B 1.72
2014-03-31 $4.34B $2.65B 1.64
2013-12-31 $4.47B $2.96B 1.51
2013-09-30 $4.34B $2.56B 1.70
2013-06-30 $4.21B $2.33B 1.81
2013-03-31 $3.95B $2.28B 1.73
2012-12-31 $3.90B $2.19B 1.78
2012-09-30 $3.75B $2.17B 1.73
2012-06-30 $3.75B $2.16B 1.73
2012-03-31 $3.74B $2.11B 1.77
2011-12-31 $3.57B $2.56B 1.39
2011-09-30 $3.61B $2.38B 1.52
2011-06-30 $3.76B $2.52B 1.49
2011-03-31 $3.76B $2.39B 1.57
2010-12-31 $3.56B $1.81B 1.97
2010-09-30 $3.46B $1.72B 2.01
2010-06-30 $3.63B $1.63B 2.23
2010-03-31 $3.36B $1.64B 2.05
2009-12-31 $3.29B $1.72B 1.91
2009-09-30 $3.26B $1.58B 2.06
2009-06-30 $3.02B $1.42B 2.13
2009-03-31 $2.91B $1.34B 2.17
Sector Industry Market Cap Revenue
Medical Medical Services $12.109B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $124.299B 15.60
Cencora (COR) United States $46.379B 18.08
ICON (ICLR) Ireland $25.848B 24.40
DiDi Global (DIDIY) China $20.706B 0.00
Avantor (AVTR) United States $14.726B 21.68
CochLear (CHEOY) Australia $13.973B 0.00
Natera (NTRA) United States $13.533B 0.00
Revvity (RVTY) United States $13.407B 23.52
Medpace Holdings (MEDP) United States $12.205B 40.15
EUROFINS SCIENT (ERFSF) Luxembourg $10.989B 0.00
Charles River Laboratories (CRL) United States $10.790B 20.66
Solventum (SOLV) United States $9.423B 0.00
Sonic Healthcare (SKHHY) Australia $7.951B 0.00
HealthEquity (HQY) United States $7.177B 46.08
Doximity (DOCS) United States $5.537B 38.78
Bausch + Lomb (BLCO) Canada $5.309B 21.25
Organon (OGN) United States $5.246B 4.98
PACS (PACS) United States $4.392B 0.00
Life Times (LTH) United States $3.563B 37.33
Sotera Health (SHC) United States $3.281B 16.10
GoodRx Holdings (GDRX) United States $3.193B 121.57
Surgery Partners (SGRY) United States $3.177B 29.07
Agilon Health (AGL) United States $2.838B 0.00
Progyny (PGNY) United States $2.569B 44.23
NovoCure (NVCR) Jersey $2.296B 0.00
AMN Healthcare Services Inc (AMN) United States $2.102B 8.33
Premier (PINC) United States $1.927B 8.24
BrightSpring Health Services (BTSG) United States $1.794B 0.00
Teladoc Health (TDOC) United States $1.696B 0.00
Alignment Healthcare (ALHC) United States $1.591B 0.00
Ryman Healthcare (RYHTY) New Zealand $1.566B 0.00
Establishment Labs Holdings (ESTA) $1.224B 0.00
GeneDx Holdings (WGS) United States $0.752B 0.00
CareDx (CDNA) United States $0.739B 0.00
Embecta (EMBC) United States $0.738B 5.02
InnovAge Holding (INNV) United States $0.691B 0.00
Pediatrix Medical (MD) United States $0.609B 6.46
Auna S.A (AUNA) Luxembourg $0.600B 0.00
QDM (QDMI) Hong Kong, SAR China $0.583B 15.27
COMPASS Pathways (CMPS) United Kingdom $0.455B 0.00
Enhabit (EHAB) United States $0.441B 44.00
ModivCare (MODV) United States $0.375B 7.02
Sonida Senior Living (SNDA) United States $0.369B 0.00
LifeMD (LFMD) United States $0.329B 0.00
DocGo (DCGO) United States $0.294B 16.06
Sharecare (SHCR) United States $0.292B 0.00
MultiPlan (MPLN) United States $0.281B 0.00
Sera Prognostics (SERA) United States $0.261B 0.00
Beauty Health (SKIN) United States $0.244B 0.00
Ascend Wellness Holdings (AAWH) United States $0.196B 0.00
Biodesix (BDSX) United States $0.184B 0.00
So-Young (SY) China $0.114B 55.25
Pono Capital Two (PTWO) United States $0.072B 0.00
Co-Diagnostics (CODX) United States $0.050B 0.00
NeueHealth (NEUE) United States $0.044B 5.99
IceCure Medical (ICCM) Israel $0.037B 0.00
Oncology Institute (TOI) United States $0.034B 0.00
Nutex Health (NUTX) United States $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.027B 0.00
BIMI Holdings (BIMI) United States $0.024B 0.00
Singular Genomics Systems (OMIC) United States $0.024B 0.00
OncoCyte (OCX) United States $0.023B 0.00
KindlyMD (KDLY) $0.016B 0.00
SeaStar Medical Holding (ICU) United States $0.012B 0.00
DermTech (DMTK) United States $0.011B 0.00
XWELL (XWEL) United States $0.011B 0.00
TRxADE HEALTH (MEDS) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.008B 0.00
ISpecimen (ISPC) United States $0.007B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Singapore $0.004B 0.00
OpGen (OPGN) United States $0.003B 0.00
Aclarion (ACON) United States $0.002B 0.00
Assure Holdings (IONM) United States $0.002B 0.00